A Phase II Study Of Sunitinib In Combination With Irinotecan, l-Leucovorin, And 5-Fluorouracil In Patients With Unresectable Or Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2011
At a glance
- Drugs Fluorouracil; Irinotecan; Levofolinic acid; Sunitinib
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2010 Planned end date changed from 1 May 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.